Search
forResearch 10 of 1000+
- Epidermal growth factor receptor mutant T790M-L858R-V948R inhibitor from Calophyllum inophyllum L. leaf as potential non-small cell lung cancer drugs
- Cutaneous Side Effects in Non-Small Cell Lung Cancer Patients Treated with Iressa (ZD1839), an Inhibitor of Epidermal Growth Factor
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer
- Redox-Modulatory and MET-Inhibitory Triad: Synergistic Cytotoxicity of L-cysteine, NAC, and MET Inhibition in Cervical Cancer Cells
- Trichomegaly of the Eyelashes After Treatment with Erlotinib in Non-small Cell Lung Cancer
- Epidermal Notch signalling: differentiation, cancer and adhesion
- Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Successful treatment of epidermal growth factor receptor inhibitor–induced alopecia with doxycycline
Learn 3 of 14
All learn results →Community 5 of 49
- How soon is hair clone? Next five years?!
- Sunlight: Does it Stimulate Hair Growth or Hair Loss?
- Can somebody tell my why Scube3 is not going to work?
- Expectations control for SCUBE3
- Twist-1 vs Scube-3. Is it worth pursuing both?